2022
DOI: 10.1128/jcm.00898-22
|View full text |Cite
|
Sign up to set email alerts
|

Fully Automated EUCAST Rapid Antimicrobial Susceptibility Testing (RAST) from Positive Blood Cultures: Diagnostic Accuracy and Implementation

Abstract: The objective of this study was to evaluate the accuracy and robustness of a fully automated EUCAST RAST (rapid antimicrobial susceptibility test) directly from positive blood culture and to appreciate its implementation constraints. This study was conducted in two phases: (i) spiked blood culture bottles (BCs) using 779 non-duplicate clinical isolates and (ii) a prospective clinical trial including 534 positive BCs sequentially processed in routine at the Bacteriology Laboratory of Geneva University Hospitals. Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
3
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(4 citation statements)
references
References 17 publications
0
3
1
Order By: Relevance
“…The biggest problem we encountered for this bacterial species was that the diameter of the inhibition zone was not formed in many studies. Although Cherkaoui reported that this problem could be solved by prolonging the incubation period while evaluating the susceptibility results of ceftazidime and cefepime in RAST studies for P. aeruginosa, we found that prolonging the incubation period did not lead to a change in the results in our study (Cherkaoui et al 2022). ).…”
Section: Discussioncontrasting
confidence: 57%
See 1 more Smart Citation
“…The biggest problem we encountered for this bacterial species was that the diameter of the inhibition zone was not formed in many studies. Although Cherkaoui reported that this problem could be solved by prolonging the incubation period while evaluating the susceptibility results of ceftazidime and cefepime in RAST studies for P. aeruginosa, we found that prolonging the incubation period did not lead to a change in the results in our study (Cherkaoui et al 2022). ).…”
Section: Discussioncontrasting
confidence: 57%
“…This poses di culties in evaluation for this antibiotic. Cherkaoui et al They reported that it is not correct to use RAST for imipenem and this antibiotic be excluded from the antibiotic panel to be tested for P. aeruginosa (Cherkaoui et al 2022). However, our results for meropenem were quite promising for P. aeruginosa.…”
Section: Discussionmentioning
confidence: 99%
“…A minor limitation of the study is the fact that the workflow for positive stool samples did not reach the predefined TAT goal of 65 h. However, stool samples represent only 4% of the caseload, and only 5% of them are positive, which makes the standardization of the workflow for these isolated specimens difficult. Furthermore, while previous studies by Cherkaoui and colleagues also highlighted the potential of automation to reduce TAT for other critical samples such as blood culture ( 33 ), the caseload for this sample type in the JCS laboratory was too low to be included in the present study. Moreover, the present study looked at the impact of a bundled intervention, i.e., implementation of WASPLab and VITEK MS systems.…”
Section: Discussionmentioning
confidence: 91%
“…Newly developed tools, like the Pheno® system (Accelerate Diagnostics), or Vitek® Reveal™ (Biomérieux) offer rAST results in 7h and 5.5h, respectively. EUCAST RAST disk diffusion can deliver even faster AST results (as early as 4h), comes at a low cost and has proven to be a valuable tool [8][9][10], but does not provide quantitative MIC values, is fairly laborious with exact intervals and manual reading (although automation is possible [11,12]), as well as only providing breakpoints for a selection of species and antibiotic agents.…”
Section: Introductionmentioning
confidence: 99%